Ignite Creation Date:
2024-05-06 @ 2:11 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04246866
Status:
COMPLETED
Last Update Posted:
2021-02-11
First Post:
2020-01-06
Brief Title:
First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration
Sponsor:
Gemini Therapeutics Inc
Organization:
Gemini Therapeutics Inc
Organization Data
Organization:
Gemini Therapeutics Inc
Class:
INDUSTRY
Study ID:
GEM-CL-10301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gemini Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None